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The effects of UVA-I and solar simulated radiation on skin sensitivity to thermal and mechanical stimuli were
compared in normal volunteers. Individual minimal erythema doses (MED) for each source were determined and
previously unexposed buttock skin was exposed to 1, 2 and 3 MED of each spectrum. Erythema, and mechanical
and thermal pain thresholds were quantiﬁed from 3 to 72 hours post-irradiation. Irradiated skin did not exhibit pain
but hyperalgesia and allodynia were provoked by the applied stimuli after exposure to 2 or 3 MED. There were
highly signiﬁcant decreases in thresholds for both stimuli in exposed skin compared with non-exposed skin. These
changes began within a few hours of irradiation, peaked about 24 hours later and persisted throughout the test
period. The sensitivity changes broadly followed the erythema response and did not extend beyond the irradiated
area. There were only minor differences between the two spectra at comparable erythemal doses. These data
demonstrate the usefulness of UVR-induced inﬂammation as a model of cutaneous hypersensitivity. This model
has clinical relevance for the study of hyperalgesia in general and the abnormal sensitivity of sunburnt skin in
particular. It is likely to be useful in the assessment of peripherally acting analgesic drugs.
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The acute clinical effects of solar ultraviolet radiation (UVR)
on human skin have been well described, especially
inflammation manifest as erythema/sunburn that is maximal
at about 18 to 24 h after exposure to solar-simulated
radiation (SSR) (Young et al, 1996; Harrison and Young,
2002). Several laboratories have shown that UVR exposure
increases skin blood flow (Young et al, 1985; Diffey et al,
1987; Frodin et al, 1988; Andersen et al, 1991; Benrath et al,
2001). The wavelength dependency (action spectrum) for
human erythema has been characterized (McKinlay and
Diffey, 1987), most recently by Anders et al (1995) and
Young et al (1998), and it has been established that UVB
(280–320 nm) is 2 to 4 orders of magnitude more effective
per unit UVR dose than UVA (320–400 nm). Analysis of
action spectra for erythema suggests different chromo-
phores for erythema induced by UVB and UVA (Anders et al,
1995). One study showed that UVA-induced erythema is
oxygen dependent (as are many UVA responses) and that
UVB-induced erythema is oxygen independent (Auletta
et al, 1986).
The mechanisms of UVR-induced inflammation are
incompletely understood (Clydesdale et al, 2001) but there
is increasing evidence that cutaneous nerve cells may play
a part by the UVR-induced release of neuropeptides and
neurotransmitters such as calcitonin gene-related peptide
(CGRP) and a-melanocyte-stimulating hormone (Seiffert
and Granstein, 2002).
In addition to inflammation it is commonly appreciated
that UVR frequently gives rise to altered skin pain sensitivity.
Notably, sunburnt skin exhibits tenderness in which the
threshold for applied stimuli to produce pain is reduced
(allodynia) and the degree of pain elicited by suprathreshold
stimuli is enhanced (hyperalgesia) and this is seen with both
mechanical and thermal stimuli. For simplicity we refer to
these changes here as hyperalgesia. This type of hyper-
algesia is observed in a variety of inflammatory conditions
(reviewed in Raja et al, 1999) and it can be of considerable
clinical importance. The mechanism of such hyperalgesia is
not fully understood. It may arise because of a sensitization
of the nociceptive sensory neurons innervating inflamed
tissue and it may have a contribution from altered spinal
cord processing of sensory information (Julius and Bas-
baum, 2001). The peripheral mediators of hyperalgesia are
also not well characterized. A large number of inflammatory
mediators, such as prostaglandins, leukotrienes, bradyki-
nin, and nerve growth factor can produce some forms of
sensory neuron sensitization, but it is not known which are
specifically responsible (see Levine and Reichling, 1999).
The nonsteroidal anti-inflammatory drugs target prostaglan-
din synthesis, but the limited effectiveness of these drugs in
many clinical conditions argues for the involvement of other
mediators. The hyperalgesia associated with sunburn was
first reported by Harrison et al (1996) and has been little
studied since. Apart from providing a better understanding
of fundamental pain mechanisms, the definition of such
changes is important for the development and assessment
of effective treatments for sunburn, and perhaps other
inflammatory conditions of the skin. One recent study
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reported the hyperalgesia associated after exposure to
broad-spectrum UVR (Benrath et al, 2001). Two other recent
studies reported a decrease of heat and mechanical pain
thresholds in human skin after exposure to 3 minimal
erythema doses (MED) of UVB radiation (Bickel et al, 1998;
Hoffmann and Schmelz, 1999) but stated that limited doses
of UVA had no effect. Here, we report on the time-course
and dose dependence of sensory changes in the skin of
sun-sensitive volunteers (skin types I/II) after exposure to
clinically relevant doses of SSR and with comparable levels
of erythema induced by UVA-I (340–400 nm). We were
interested in determining if erythema per se is a reliable
indicator of skin sensitivity, especially as it has been
suggested that a UVA-induced erythema is not a sunburn
(Willis and Cylus, 1977) because sunburn cells (apoptosis),
typical of UVB, were not observed in the epidermis.
Some forms of inflammatory stimuli induce widespread
sensory changes, extending well outside the treated area
(Raja et al, 1999). We wished to determine whether the
sensory changes occurring in UVR-induced inflamma-
tion colocalized with inflammatory responses or were
more widespread, as this has both theoretical and practi-
cal implications for the interpretation of our data (see
Discussion).
Results
Study I: Time-course and dose–response of thermal and
mechanical hyperalgesia As expected, the irradiated sites
showed a progressive reddening for about 24 h. At 24 h,
skin exposed to a 1 MED SSR or UVA-I showed clear
erythema with a boundary matching the area irradiated.
Skin exposed to 2 and 3 MED also sometimes showed
edema. No irradiated skin developed blisters, and volun-
teers did not report ongoing (unprovoked) pain at any of the
sites. The erythema gradually faded over the next few days.
The only apparent longer-term sequela of irradiation was
tanning of the skin at irradiated sites.
The time-courses of changes in erythema and skin
sensitivity after SSR and UVA-I Figure 2 shows the mean
changes in erythema (Fig 2a), thermal pain threshold (Fig
2b), and mechanical pain threshold (Fig 2c) on sites
exposed to 3 MED SSR and UVA-I. Erythema developed
with both spectra, but with slightly different time courses.
The SSR induced a more rapidly rising erythema, first
significantly different (po0.001) from unirradiated sites at 3
h, and peaking at 24 h. UVA-I induced erythema developed
more slowly, and did not peak until 48 h with this dose. The
magnitude of erythema (measured as skin reflectance) was
significantly higher (po0.001) for SSR than for UVA-I with a
3 MED dose at all time points except 3 and 48 h.
Comparable results were obtained with 2 MED except that
significant differences (po0.001) between the two sources
were only seen at 6 and 9 h (data not shown).
As erythema developed there were very marked changes
in thermal and mechanical pain thresholds. The thermal
thresholds (Fig 2b) dropped progressively over the observa-
tion period. The mean peak decrease at 3 MED (  SEM,
n¼12) were 7.3  0.81C for UVA-I and 6.2  0.81C for SSR
at 24 and 48 h, respectively. These were significantly
different (po0.001) from control skin (mean threshold-
¼ 45.8  0.71C). This thermal hyperalgesia reduced the
thermal threshold to only a few degrees above normal skin
temperature. The onset of thermal hyperalgesia developed
quicker for UVA-I than for SSR (in contrast to the onset of
erythema). As shown in Fig 2(b), there were significant
differences between the spectra at 3, 6, and 24 h. After 24
h, the maximal thermal hyperalgesia was approximately
maintained for both UVA-I and SSR for the remainder of the
testing period. Sites treated with 2 MED showed similar
time courses for the onset of hyperalgesia but with some
reversal at 72 h (data not shown).
As shown in Fig 2(c), skin treated with 3 MED became
hyperalgesic to mechanical stimuli with a time course that
closely paralleled the development of erythema and there
were no significant differences (p40.5) between the two
spectra. Thus, mechanical threshold appeared to drop
slightly faster for the SSR irradiated skin and became
significantly different from control (p¼0.02) at 6 h.
Mechanical hyperalgesia progressively increased in magni-
tude, reaching a maximum after 48 h. The average
mechanical threshold (  SEM, n¼ 6) at control sites was
95.2  5.0 g. At 24 h this had decreased to 26.7  10.9 g
and 31.7  12.9 g for SSR and UVA-I, respectively. The
mechanical hyperalgesia reached an approximate plateau
for the remainder of the observation period. The drop in
threshold was sufficiently pronounced that brushing the
irradiated skin was sufficient to elicit pain in most volunteers
(i.e., allodynia). The degree of mechanical hypersensitivity
was uniform across the 3 MED site. Skin exposed to lower
UVR doses showed a lesser effect but a similar time course
of onset of hyperalgesia (data not shown). With 1 MED,
mechanical hyperalgesia was less consistently observed,
although when present it too appeared to be maximum 24 h
after irradiation.
The statistical analyses, based on delta data, showed
that for erythema there was a significant effect of time,
source, and interaction between time and source. For heat
pain, there was a significant effect of time, source but
no interaction between time and source. In the case
Figure1
Emission spectra of SSR and UVA sources. The erythemally effective
energy (EEE) of the SSR source is about 92% for UVB (280–320 nm)
and 8% for UVA (320–400 nm). EEE for the UVA source is 95.1% for
UVA-I (340–400 nm), 4.2% for UVA-II (340–400 nm), and 0.7% for UVB
(280–320 nm).
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of mechanical pain, there was a significant effect of time
(9–72 h) but no interactions.
The dose–response for erythema and hyperalgesia with
SSR and UVA-I Figure 3 shows the mean changes in
erythema (DEI) (Fig 3a), thermal pain threshold (Fig 3b), and
mechanical pain threshold (Fig 3c) 24 h after irradiation (i.e.,
approximately peak changes) for different doses of SSR
and UVA-I. All three parameters show a strong dose-
dependency and this is statistically significant (po0.05).
Figure 3(a) shows very comparable levels of 24 h erythema
with 1 and 2 MED SSR and UVA-I; however, a clear plateau
is seen with 3 MED UVA-I (at which edema was noted in a
majority of volunteers), whereas increased erythema is seen
with 3 MED SSR. Figures 3(b) and 3(c) show comparable 24
h mean dose–response curves for SSR and UVA-I-induced
increases in skin sensitivity to heat and mechanical pain,
respectively.
Statistical analyses showed a significant effect of SSR
and UVA-I dose and source, and interaction between dose
and source for erythema. The heat pain data show a
significant effect of dose (po0.01) and an interaction
between dose and source, but no effect of source. In the
case of mechanical pain, there was a significant effect of
dose (po0.05) but not effect of source or interaction
between dose and source.
Study II: Spatial distribution of mechanical hyperalge-
sia Figure 4 shows that, as expected, the mechanical pain
threshold fell by about 50% within the irradiated area. Sites
B and C are significantly different from sites A, D, E, and F
(po0.001), even though site D is 3 mm from site C. In
summary, the data show that mechanical hyperalgesia is
highly localized to the area of inflammation.
Figure 2
The time-courses for 3 MED SSR and 3 MED UVA-I-induced
increases in skin sensitivity are similar. Measurements for erythema
(a), heat pain (b), and mechanical pain (c) thresholds for 3 MED SSR and
UVA-I were made 3 to 72 h after exposure. Each volunteer was exposed to
the two spectra on contralateral buttocks. The mean data shown  SEM
are differences between UVR exposed and nonexposed sites.
Figure3
The 24 h dose–response curves for SSR and UVA-I-induced
increases in skin sensitivity are similar. Dose–response studies for
erythema (a), heat pain (b), and mechanical pain (c) thresholds were
assessed at 24 h postirradiation with SSR and UVA-I; note that edema
was often observed with 3 MED UVA. Each volunteer was exposed to
the two spectra on contralateral buttocks. The mean data
shown  SEM are differences between UVR exposed and nonexposed
sites.
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Discussion
Our results show that SSR and UVA-I result in marked
increases in skin sensitivity to thermal and mechanical
stimuli. This sensitization can be so severe that moderate
heating of the skin or gentle touch can produce pain. Our
findings with SSR are in agreement with previously
published work (Hoffmann and Schmelz, 1999; Benrath
et al, 2001). That is, doses in excess of 1 MED lead to
hyperalgesia that develops over several hours, peaks at
about 24 h and then slowly declines over several days, at a
rate that depends on the initial dose. We found the changes
in skin sensitivity paralleled the erythema associated with
SSR. The study by Benrath et al (2001) suggested that the
erythema has two phases, one peaking at 12 h and the
second at 36 h. This study and other studies (Young et al,
1985; Frodin et al, 1988; Andersen et al, 1991; Hoffmann
and Schmelz, 1999; Harrison and Young, 2002) have
observed a monophasic response, and it is not clear if this
discrepancy relates simply to the sampling intervals used in
the different studies. In any case, the sensory changes
observed by Benrath et al (2001) were also monophasic.
The SSR doses we examined are clinically relevant and
could be obtained from summer sun within an hour or so at
temperate latitudes.
Previous studies have concluded that UVA produces
very limited hyperalgesia (Bickel et al, 1998; Hoffmann and
Schmelz, 1999); however, both of those studies used very
low doses. Bickel et al (1998) compared UVB and UVA. The
UVB dose was defined as 3 MED. The UVA protocols were
not clearly defined but appear to have been suberythemal.
To compare the effects of UVA and the UVB content of SSR
we chose to use comparable erythema doses. Whereas the
mechanisms of UVA and UVB inflammation may differ
(Auletta et al, 1986), we found that skin sensitization was
broadly similar for UVA-I and SSR. The time-courses for
SSR and UVA-I-induced changes in skin sensitivity were
very similar as shown in Fig 2(b,c). Furthermore, the 24 h
SSR and UVA dose–response curves for induced sensitivity
to both heat and mechanical pain were very similar. Such
UVA doses are higher than would normally be obtained from
sunlight. Interestingly, as shown in Fig 3(a), the level of UVA
erythema did not appear to increase between 2 and 3 MED
(unlike SSR). This may have been a consequence of edema
induced at this dose.
UVB accounts for under 10% of the UVR in the SSR
source; however, when the SSR emission spectrum is
biologically weighed with the CIE action spectrum for
erythema (McKinlay and Diffey, 1987) the UVB accounts
for about 90% of the erythemal efficacy of the SSR
spectrum. The relationship between erythema (by SSR
and UVA) and change in skin sensitivity suggests that it is
primarily the UVB content of SSR that is responsible for its
observed effects and obviously, conclusions about differ-
ences in the effects of UVB and UVA can only be drawn
when erythemally equivalent doses are given.
There is evidence from experimental and action spec-
trum studies to suggest that the mechanisms of UVB- and
UVA-induced erythema are different (Auletta et al, 1986;
Anders et al, 1995) even though the slopes of the dose–
response curves for UVB- and UVA-induced erythema are
similar (Diffey and Farr, 1991). Our data suggest, however,
that irrespective of differences in mechanism, the con-
sequences as assessed by skin sensitivity are similar. We
feel that this means that a UVA-induced erythema can be
defined as a sunburn, contrary to the suggestion made by
Willis and Cylus, 1977) whose definition was based on the
lack of characteristic UVB-induced epidermal apoptosis
after UVA exposure. Our data show that comparable
degrees of erythema, whether caused by SSR (i.e., primarily
by UVB) or UVA-I, result in comparable ‘‘tenderness’’ to
mechanical and thermal stimuli. This ‘‘tenderness’’ is surely
more important to the person with the sunburn than the
histologic changes in the epidermis.
The mechanism of hyperalgesia is not revealed by these
studies. It is known, however, that several algogenic
chemicals are released with UVR-induced inflammation
(Hruza and Pentland, 1993; Clydesdale et al, 2001). Several
prostaglandins, including D2, E2, and F2 (Rhodes et al,
2001), appear in UVR inflammation within a few hours and
some persists for several days. Prostaglandin E2 is capable
of sensitizing the peripheral terminals of nociceptors to
thermal stimuli (Levine and Reichling, 1999) and so could
contribute to UVR-induced hyperalgesia. There is some
evidence that cyclooxygenase inhibitors applied topically to
UVR-inflamed skin can reduce some of the hyperalgesia
(Bayerl et al, 1998). Several other inflammatory mediators
are released in UVR-exposed skin, including histamine,
bradykinin, cytokines, such as interleukins 1 and 10, tumor
necrosis factor a, and nerve growth factor (Barr et al, 1999;
Seiffert and Granstein, 2002). Again there is abundant
Figure 4
SSR-induced changes in sensitivity to mechanical pain are
localized. A ring of skin was exposed to 3 MED SSR (a). Sensitivity
to mechanical pain was assessed inside (A), within (B,C) and varying
distances outside (D–F), the ring at 24 h. The sensitivity to pressure
data (b) shown are mean  SEM.
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evidence that these mediators can induce sensitization in
some nociceptors. There is also abundant evidence that
nerve growth factor contributes to the hyperalgesia asso-
ciated with many types of inflammation (McMahon and
Bennett, 1999). Benrath et al (2001) have suggested that the
sensory neuropeptides substance P and CGRP are re-
leased from nociceptors and contribute to the later phase of
UVR-induced hyperalgesia. These agents are also thought
to be involved in immunosuppression by UVR (Seiffert and
Granstein, 2002). Whatever the mediators, a likely molecular
mechanism for thermal hyperalgesia is the sensitization of
transient receptor potential (TRP) channels expressed in
primary afferent nociceptors. Most notably, the sensitization
of TRPV1 (formally vanilloid receptor 1, VR1) leads to a
marked increased in heat sensitivity (see Di Marzo et al, 2002).
A particularly interesting issue is the cause of mechanical
hyperalgesia, which was frequently marked to the extent
that a light touch or brush-elicited pain (i.e., allodynia).
Whereas a great many factors have been shown to induce a
peripheral sensitization of cutaneous nociceptors to thermal
stimuli, there are only occasional reports of mechanical
sensitization in these fibers. There is a very considerable
body of work showing that activity in nociceptors can
trigger changes in the central (particularly spinal cord)
processing of sensory information, and that this so-called
central sensitization can account for some forms of
mechanical hyperalgesia (Woolf and Salter, 2000). Because
the central representation of the body surface has a finite
resolution, however, centrally mediated mechanical hyper-
algesia (also referred to as secondary hyperalgesia) is seen
to extend beyond the boundaries of tissue injury (Raja et al,
1999). It is striking that the mechanical hyperalgesia seen
with sunburn is restricted to the exact area of UVR
exposure, as we explicitly examined and reported in this
study. This very strongly suggests that the mechanism of
this hyperalgesia is peripheral sensitization of nociceptors
and that there must therefore be one or more peripheral
mediators responsible for triggering it. As mechanical
hyperalgesia is a common clinical problem associated with
many disorders, identification of such mediators is likely to
be of considerable clinical use and UVR inflammation offers
the potential to do so.
Together, the current data demonstrate the usefulness of
UVR-induced inflammation as a model of primary hyper-
algesia. It is possible to use this stimulus quantitatively.
Volunteers experience little or no discomfort during the
irradiation and subsequently, whereas the skin becomes
tender, there is no evidence of spontaneous tissue injury or
pain. Multiple sites can be exposed, closely sited, and with
different degrees of inflammation. Sensory changes are
extremely robust and subjects are easily blinded with
respect to treatments. Sunburn-associated hyperalgesia
has self-evident clinical relevance in itself, and it can be
used to study inflammatory hyperalgesia in general. UVR
inflammation can be used for the assessment of periph-
erally acting analgesic drugs.
Materials and Methods
Volunteers and studies Eighteen adult volunteers of skin types I/
II were identified by phenotype and questionnaire. They gave
informed consent to take part in the study that was approved by
the Ethics Committee of St Thomas’ Hospital, London, UK. The
studies conformed to Declaration of Helsinki guidelines. All
volunteers were healthy and not on any medication. The test sites
were on previously unexposed buttock skin.
There were two studies and the population demographics are
given in Tables I and II, respectively.
In study I, we assessed the dose- and time-dependent effects
of SSR and UVA-I on the same 12 volunteers. The endpoints were
changes in skin sensitivity to thermal and mechanical stimuli. In
study II, we determined if any changes in skin sensitivity, to a
mechanical stimulus, were localized to the site of irradiation. In six
volunteers (and in different experiments from those described in
study I) we irradiated an annulus of skin (Fig 4) with 3 MED of SSR.
The annulus was 60 mm in diameter and had a 20 mm central
unirradiated zone. Twenty-four hours after irradiation, we tested
the mechanical sensitivity at sites illustrated in Fig 4 across the
irradiated zone.
UVR sources and dosimetry SSR was obtained from a Solar
Simulator (Oriel, Stratford, Connecticut) using a 1 kW xenon arc
lamp (ORC Lighting Products, Azusa, California) in conjunction
with a quartz collimator, quartz lens and a Schott WG320 filter (1
mm thick). Irradiance was routinely measured with a wide-band
thermopile radiometer (Medical Physics, Dryburn Hospital, Dur-
ham, UK) calibrated with a double-monochromator spectroradi-
ometer (DM150, Bentham, Reading, UK), which had been
calibrated against a National Physics Laboratory (NPL) standard
lamp. Irradiance was about 15 mW per cm2 scanned between 280
and 400 nm (UVB 280–320 nm accounting for 8.5% of total output)
at the skin surface (a distance of 11 cm). Broad-spectrum UVA-I
(340–400 nm) was obtained from a UVASUN2000 (Mutzhas,
Munich, Germany). Routine irradiance was measured with an IL
442 radiometer (International Light, Newburyport, MA) and
calibrated in the same way as the thermopile used for SSR.
Irradiance was 78 mW per cm2 (over the spectral range 340–400
nm) on skin surface (a distance of 10 cm); 98.88% of total output
was UVA-I (340–400 nm), 1.11% was UVA-II (320–340 nm), and
0.01% was UVB (280–320 nm). The SSR and UVA spectra are
shown in Fig 1.
Irradiation protocol Individual sensitivity to UVR was assessed
by the determination of the MED defined as the dose required to
produce a definite border erythema 24 h after exposure. This was
done by exposing six 1 cm2 areas of previously unexposed buttock
skin to a UVR dose series with
p
2 increments. The pain sensitivity
studies were also performed on previously unexposed buttock
skin. In study I, sites (2.5 cm  2.5 cm) were irradiated with 1, 2,
and 3 MED SSR on one buttock and with UVA-I on the other.
Levels of erythema and pain thresholds to thermal and mechanical
stimuli were assessed at each site 3, 6, 9, 24, 48, and 72 h after
exposure. The irradiation room was air conditioned at 201C and a
fan was positioned to blow over the UVA-I irradiated site to
minimize any increases in skin temperature. In study II, the effects
of 3 MED SSR were assessed at 24 h. The experimental detail is
given in Fig 4.
Monitoring the biologic effects of UVR
Erythema Erythema expressed as the erythema index (EI) was
measured with a reflectance device (Dia-stron, Andover, UK). The
EI is Log10 (reflected red light (reference spectrum)/reflected green
light (which is absorbed by hemoglobin)) (Diffey et al, 1984).
Triplicate readings were taken at each site. A control reading from
an adjacent nonexposed site was always taken and subtracted on
a person by person basis from the values taken at irradiated sites.
This value is referred to as DEI.
Skin sensitivity to thermal and mechanical stimuli Sensitivity of
irradiated and control skin was determined by monitoring the pain
threshold to graded thermal and mechanical stimuli. Prior to any
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experimentation, the volunteers had a training session to familiar-
ize themselves with the sensations caused by the test systems and
define their levels of heat and mechanical pain thresholds. At this
point the challenge was stopped. Volunteers could not see and
were unaware of the specific UVR treatments to the test sites,
including a nonirradiated control site on each buttock.
Sensitivity to thermal challenge was assessed with a TSA-2001
Thermal Sensory Analyzer (Medoc, Israel). A 2  2 cm probe was
held against the subject’s skin at a site of irradiation. The initial
application temperature of the probe was 301C. Skin temperature
was then increased at a rate of 0.51C per s until the volunteer
judged the heat stimulus painful, which was signaled by the
subject with an electronic push button. A computer logged the
temperature as the thermal pain threshold. Immediately after
signaling the pain threshold, the thermal probe is actively cooled
back to a temperature of 301C. For each subject and at each time
point, eight skin sites were tested in pseudo-random order.
Sensitivity to mechanical challenge was assessed with an
electronic von Frey System (Somedic, Ho¨rby, Sweden). This device
has a plastic monofilament (1 mm in diameter) attached to a
transducer, which records applied pressure. The probe is held by
the experimenter and pushed against the skin to increase pressure
at a rate of 4 g per s. The pressure increase was monitored on a
computer screen, and the experimenter matches the actual
applied force against a template of required force. Pressure was
increased until subjects judged the stimulus to be painful, which
they indicated with an electronic push button. The force exerted at
this time was recorded as the mechanical pain threshold.
Data analysis The data were analyzed in by ANOVA for mixed
models using SAS Version 8.2. In study I, delta values were used in
the time-course studies (i.e., 3 MED0 MED). Raw data were used
with the dose–response studies except for heat pain because the
control values for each source (0 MED) were significantly different.
The mixed models comprise (1) a random effect for subject, and (2)
fixed effects for UVR source and time or dose, and interaction
between UVR source and either time or dose. In study II, in which
site was a fixed factor and subject a random factor, the Tukey
procedure was used for multiple comparisons. Statistical signifi-
cance was set at p less than 0.05 (), p less than 0.01 (), and p
less than 0.001 () as indicated on the relevant figures.
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